Concert Pharmaceuticals has received US patent for CTP-499, its drug candidate being developed for the treatment of diabetic nephropathy. CTP-499 is a potential treatment developed on the basis of DCE Platform for diabetic nephropathy, a ...
Critical Outcome Technologies has received a patent for its advanced oncology drug candidate, from the US Patent and Trademark Office. The patent covers the synergistic effects of combination therapies containing COTI-2 and members of ...
Tags: oncology drug, COTI-2, anti cancer agents
IDG News Service-Apple and Samsung will return on Thursday to the San Jose courtroom where they battled over cell phone patents earlier this year,and Apple subsequently won damages of$1.05 billion. The late August trial saw both companies ...
Tags: Apple, Samsung, cell phone patents, iPhone
Coronado Biosciences has received notice of allowance for US patent application covering CNDO-109, from the US Patent and Trademark Office (USPTO). The patent is entitled, Method for activating natural killer cells by tumor cell ...
Tags: CNDO-109, cancer cells, AML
The US Court of Appeals for the Federal Circuit has upheld that the Myriad Genetics composition of matter claims covering isolated DNA of the BRCA 1 and BRCA 2 genes are patent-eligible material under Section 101 of the US Patent Act. ...
Tags: BRCA 1 genes, BRCA 2 genes, isolated DNA, Myriad Genetics
Neurotez has received US patent covering hormone Leptin for treating Alzheimer's disease (AD) resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid ...
Tags: Leptin, Alzheimer's disease, endogenous pluripotent hormone
NewLink Genetics has received a notice of allowance for a Japanese patent entitled, Antitumor Vaccination Using Allogeneic Tumor Cells Expressing Alpha (1,3)-Galactosyltransferase. The patent contains pharmaceutical composition claims ...
Tags: NewLink Genetics, galactosyltransferase, antitumor vaccination
US based Watson Pharmaceuticals has filed a legal case against US Food and Drug Administration's (FDA) decision regarding the company's exclusivity for its generic version of Actos (Pioglitazone Hydrochloride 15mg, 30mg and 45mg tablets). ...
Tags: Watson Pharmaceuticals, Actos, Pioglitazone Hydrochloride
Corgenix Medical has received additional patent covering its AspirinWorks technology from the US Patent and Trademark Office. The patent is issued for the AspirinWorks Test Kit, which measures thromboxane metabolites in urine to evaluate ...
Tags: AspirinWorks technology, AspirinWorks test kit, Corgenix Medical
The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to SkyePharma for a patent application 2012/0177734 of RAYOS (Prednisone) delayed-release tablets. The NOA covers the FDA-approved RAYOS, which uses the ...
Tags: SkyePharma, RAYOS delayed-release tablets, rheumatoid arthritis
Lighting makes up about 18% of the total electricity consumed in the U.S. and energy efficient lighting plays a major role in conservation efforts. Switching from fluorescent to LED has benefits including energy savings and longer life, ...
Tags: energy efficient lighting, LED, light
The Australian Patent Office and the patent office of Mexico, Instituto Mexicano de la Propiedad Industrial, have granted new patents to Quick-Med Technologies' polyurethane-modified polycation, a new product of the NIMBUS technology family ...
Tags: patent, polyurethane modified polycation, antimicrobial
Biotech has rceived a notice of allowance from the USPTO for a patent application covering the company's long-acting CTP-enhanced human growth hormone (hGH-CTP). Once the patent is issued, PROLOR would gain additional intellectual ...
Tags: PROLOR, CTP platform, human growth hormone
America's Impax Laboratories has begun the challenging process against the suit filed by two companies for patent infringement over a generic version of Opana® ER (oxymorphone hydrochloride extended-release) drug. Impax ...
Inovio Pharmaceuticals has received a US patent covering SynCon vaccine for cervical dysplasias and cancers caused by human papillomavirus (HPV). The patent covers Inovio's synthetic consensus HPV antigens, DNA constructs and vaccines ...
Tags: Inovio Pharmaceuticals, SynCon vaccine, HPV